Radware Announces Fourth Quarter and Full Year 2018 Earnings
Fourth Quarter 2018 Results and Financial Highlights Record Revenues of $64 Million, up 9% from the fourth quarter of 2017 […]
Red Pine Discovers Another High-Grade Structure at its Wawa Gold Project
TORONTO, Feb. 06, 2019 (GLOBE NEWSWIRE) — Red Pine Exploration Inc. (TSX-V: RPX) (“Red Pine” or the “Company”) announces that […]
TSX News -
Troilus Gold Corp. Reports Significant Increase in Share Ownership by Management and Board
TORONTO, Feb. 06, 2019 (GLOBE NEWSWIRE) — Troilus Gold Corp. (TSX: TLG; OTCQB: CHXMF) (“Troilus” or the “Company”) is pleased […]
Nabis Holdings Announces Strategic Investment in Bloombox – a Leading Intelligent Retail & Supply Chain Cannabis Software Platform
Bloombox Expected to Be Used Across Outlets in an Estimated 7-10 States in 2019 THIS NEWS RELEASE IS NOT FOR […]
Novelion Therapeutics Subsidiary Enters Into Licensing Agreement for JUXTAPID® in Japan
Out-licensing of commercialization rights allows for significant operating expense savings Upfront payments improve near-term liquidity VANCOUVER, British Columbia, Feb. 06, […]
Equinor ASA: Informasjon angående foreslått utbytte for fjerde kvartal 2018
Nøkkelinformasjon vedrørende foreslått kontantutbytte for Equinor (OSE: EQNR, NYSE:EQNR) for fjerde kvartal 2018. Utbyttebeløp: 0,26 Annonsert valuta: USD Siste dag […]
Equinor ASA: Information relating to proposed dividend for fourth quarter 2018
Key information relating to the proposed cash dividend to be paid by Equinor (OSE:EQNR, NYSE:EQNR) for fourth quarter 2018. Proposed […]
Equinor fourth quarter 2018 and year end results
Equinor (OSE: EQNR, NYSE: EQNR) reports adjusted earnings of USD 4.4 billion and USD 1.5 billion after tax in the […]
Equinors resultater for fjerde kvartal og året 2018
Equinor (OSE: EQNR, NYSE: EQNR) rapporterer et justert driftsresultat på 4,4 milliarder USD og 1,5 milliarder USD etter skatt i […]
Aeglea BioTherapeutics Announces Pricing of $60.0 Million Public Offering
AUSTIN, Texas, Feb. 06, 2019 (GLOBE NEWSWIRE) — Aeglea BioTherapeutics, Inc., (Nasdaq:AGLE) a clinical-stage biotechnology company that designs and develops […]
